Home › Funds › ZWJ INVESTMENT COUNSEL INC › BSX
ZWJ INVESTMENT COUNSEL INC position in BSX
BOSTON SCIENTIFIC CORP · Health Care
ZWJ INVESTMENT COUNSEL INC reported holding 739,647 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$32.3M, representing 1.00% of its reported portfolio and ranking #37 among its reported holdings. ZWJ INVESTMENT COUNSEL INC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How ZWJ INVESTMENT COUNSEL INC's BSX position evolved
ZWJ INVESTMENT COUNSEL INC first disclosed a stake in BSX in Q3 2023 at 634,339 shares (US$33.5M). The position peaked in Q1 2025 at 603,631 shares, worth US$60.9M. Across 13 filings, ZWJ INVESTMENT COUNSEL INC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 739,647 shares valued at US$32.3M — an increase of 149,431 shares quarter over quarter.. Notable position changes include a 25% increase in Q3 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 634.34K | $33.49M | New |
| Q4 2023 | 626.60K | $36.22M | Reduce |
| Q1 2024 | 606.14K | $41.51M | Reduce |
| Q2 2024 | 618.30K | $47.62M | Add |
| Q3 2024 | 615.54K | $51.58M | Hold |
| Q4 2024 | 617.30K | $55.14M | Hold |
| Q1 2025 | 603.63K | $60.89M | Reduce |
| Q2 2025 | 565.75K | $60.77M | Reduce |
| Q3 2025 | 565.01K | $55.16M | Hold |
| Q4 2025 | 571.01K | $54.45M | Add |
| Q1 2026 | 704.10K | $44.18M | Add |
| Q2 2026 | 590.22K | $25.19M | Reduce |
| Q3 2026 | 739.65K | $32.29M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on ZWJ INVESTMENT COUNSEL INC
FAQ
How long has ZWJ INVESTMENT COUNSEL INC held BSX?
ZWJ INVESTMENT COUNSEL INC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ZWJ INVESTMENT COUNSEL INC's current position in BSX?
As of Q3 2026, ZWJ INVESTMENT COUNSEL INC holds 739.65K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $32.29M, representing 1.00% of its reported portfolio and ranking #37.
Has ZWJ INVESTMENT COUNSEL INC been buying or selling BSX?
In the latest 13F filing (Q3 2026), ZWJ INVESTMENT COUNSEL INC increased its position in BSX. The position peaked in Q1 2025 at 603.63K shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.